Gregoire Le Gal
MD, PhD
Senior Scientist, Inflammation and Chronic Disease
Ottawa Hospital Research Institute
Professor, Department of Medicine
University of Ottawa
Program Director, Inflammation and Chronic Disease
Ottawa Hospital Research Institute
Bio
Dr. Grégoire Le Gal, M.D., Ph.D., is a Professor in the Division of Hematology of the Department of Medicine at the University of Ottawa, a physician in the Thrombosis Program, Division of Hematology at Ottawa Hospital, and a Senior Scientist in the Ottawa Hospital Research Institute, Clinical Epidemiology Program since July 2012. He was born and trained in France.
His primary research interest is the diagnosis and management of venous thromboembolism (VTE), including the clinical diagnosis of VTE, and the derivation and validation of clinical decision rules for VTE. He has 233 peer-reviewed publications in general internal medicine and specialized journals and has had multiple international speaking invitations. He is a member of the international advisory board of the Journal of Thrombosis and Haemostasis, and a reviewer for main general internal medicine and thrombosis Journals. He has been the principal investigator of several multicenter multinational projects on the diagnosis and management of VTE. He is currently the Principal Investigator of four peer-reviewed clinical studies (Programme Hospitalier de Recherche Clinique, Ministry of Health, France).
Research Goals and Interests
Dr. Le Gal's primary research interest is the diagnosis and management of venous thromboembolism (VTE), including the clinical diagnosis of VTE, and the derivation and validation of clinical decision rules for VTE.
News
Publications
COPD exacerbation purulence status and its association with pulmonary embolism: a systematic review with meta-analysis
2025-11-01 Go to publicationPrevalence and factors associated with high-risk thrombophilia: a single-center cross-sectional study of 3550 patients at a tertiary Thrombosis Centre in Switzerland
2025-01-01Optimising communication to patients with venous thromboembolism: development of a provider toolkit
2025-01-01Prediction of health-related quality-of-life results after lung stereotactic body radiotherapy using dose-volume parameters from functional mapping on Gallium-68 perfusion PET/CT
2025-01-01Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study
2025-01-01